Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Public Policy and Advocacy Committee

Aug 1, 2025/Open Access

The APTA Public Policy and Advocacy Committee is appointed by the APTA Board of Directors. The detailed charge outlining the roles and responsibilities of this committee is provided below. 

Subcommittee on Practice and Service Awards

Aug 1, 2025/Open Access

The Awards Committee and Awards Subcommittees are appointed by the APTA Board of Directors. The detailed charge outlining the roles and responsibilities of this committee is provided below. 

Physical Therapy Educator Development

APTA has created and curated educator resources to help you develop professionally and personally and to enhance your efforts to further the profession through PT and PTA education.

Motor Neurone Disease: Assessment and Management [NG42]

Jul 23, 2019/CPG

Recommendations to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.

Congress Investigating TRICARE Issues Amid Provider and Patient Disruptions

Sep 5, 2025/News

Congress is beginning to formally investigate ongoing issues with the TRICARE system that have affected health care providers and military families who rely on the program for coverage and care.

Guidelines: Commitment of Students and Clinicians to Patients, Clients, Society, and the Profession

Aug 20, 2020/Policies & Bylaws

House guideline: APTA supports students, PTs, and PTAs expressing their commitment to patients, clients, society, and the profession with an oath or pledge.

Becoming a Better Ally and Advocate

Jun 25, 2023/APTA Social

In the spirit of Pride month and APTA PT Proud's upcoming advocacy series on LGBTQ+ legislation, June's APTA Social will focus on LGBTQ+ allyship and advocacy.

American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

Mar 31, 2015/CPG

The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.

American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Fascioscapulohumeral Muscular Dystrophy

Jul 28, 2015/CPG

Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.

Digital Health Technology and Physical Therapy

Apr 15, 2022/Statement

APTA maintains that "physical therapy," whether provided in person or virtually, is performed or directed by licensed physical therapists.